The pharmaceutical market is a dynamic mix of trends and changes – IMS helps translate these dynamics into meaningful solutions and results
IMS helps customers identify the optimal mix of products in the portfolio and pipeline enabling them to advance healthcare and achieve the best returns. Our consultants determine which therapy class to invest in, which products to license, how to achieve the right marketing mix across product portfolios and acquisitions to consider.
In a market driven by innovation, IMS advances the performance of product portfolios and delivers high-impact consulting solutions allowing clients to answer critical questions and drive performance.
